Vaasa Central Hospital, Vaasa, Finland
14
3
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.1%
1 terminated/withdrawn out of 14 trials
85.7%
-0.8% vs industry average
14%
2 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Nordic ORgan Preservation Pilot Approach Nonrandomised Single-Arm Trial for Non-Operative Management of Rectal Cancer
Role: collaborator
SEDentary Lifestyle, Mortality and Major Adverse Clinical Outcomes in Chronic KIDney Disease
Role: collaborator
Treatment of Resistant Hypertension by Renal Sympathetic Denervation in Patients Undergoing Dialysis Therapy
Role: collaborator
EVLA and Optimal Timing of Sclerotherapy
Role: collaborator
The Prevalence of Appendiceal Tumours in Periappendicular Abscess
Role: collaborator
A Study of Surgical Weight Loss to Treat Obstructive Sleep Apnea
Role: collaborator
The Finnish Faecal Microbiota Transplantation Study (FINFMT)
Role: collaborator
Implementation of Finnish Prehospital Stroke Scale to Emergency Medical Services
Role: collaborator
Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
Role: collaborator
The Recuperation of Patients After Elective Shoulder Surgery Observational Cohort Study
Role: collaborator
Laparoscopic Gastric Bypass Versus Sleeve Gastrectomy to Treat Morbid Obesity
Role: collaborator
the Use of a IPOM Mesh for Prevention of Parastomal Hernia
Role: collaborator
Intravenous Metoprolol Versus Intravenous Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery
Role: collaborator
Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events
Role: collaborator
All 14 trials loaded